Neuro-Oncology Reviews
Volume
27 Number 24
31 August 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 24, 31 August
Wu T, Zhao P, Chen Z, Ying T, Nie Z, Hua W, Li H, Mao Y, Bu W.
Neuro-Cancer Interactions Shape Glioma
Intratumoral Heterogeneity.
Adv
Sci (Weinh). 2025 Aug 21:e06694. doi:
10.1002/advs.202506694. PMID:
40841855. Review. ˍ
Iamukova L, Alferova E.
Personalized
Cancer Vaccines in the Clinical Trial Pipeline.
Asia
Pac J Clin Oncol. 2025 Aug 22. doi:
10.1111/ajco.70006. PMID:
40846676. Review. ˍ
Rahman MA, Yadab MK, Ali MM.
A modern
approach to glioblastoma using temozolomide and nanoparticles
carrier drug: a standard care of combination therapy and
treatment.
Biochem
Pharmacol. 2025 Aug 22;242(Pt 1):117276. doi:
10.1016/j.bcp.2025.117276. PMID:
40850359. Review˰
ˍ
Pace A, Solari A, Veronese S, Salmaggi A, Silvani A, Lissoni B.
Bertocchi E, Camporeale G, Fariselli L, De Panfilis L, Fausti P,
Rudà R, Merli R, Sgromo S. Iacorossi L et al.
Palliative
Care in Adult Patients with Grade III and IV Gliomas
(Le Cure Palliative nei pazienti adulti affetti da Gliomi di grado
III e IV).
Ist
Sup Sanità 2025 Aug 26. (Italian). Guidelines.
PDF.
Shetty C, Tamatta R, Dhas N, Singh AK.
Evolving
therapeutic strategies in glioblastoma: traditional approaches and
novel interventions.
3
Biotech. 2025 Aug 28;15(9):318. doi:
10.1007/s13205-025-04493-1. PMID:
40893155. Review. ˍ
Gao Q, Song D, Xu D, Chai X, Ge M.
Characteristics
of the blood-brain barrier in pediatric brain tumors.
Front
Pediatr. 2025 Aug 29;13:1646641. doi:
10.3389/fped.2025.1646641. PMID:
40948505. Review. ˍ
Valvi S, Fouladi M, Fisher MJ, Gottardo NG.
IDH
mutant high-grade gliomas.
Front
Mol Neurosci. 2025 Aug 29;18:1662414. doi:
10.3389/fnmol.2025.1662414. PMID:
40949165. Review. ˍ